Headline News about Theravance Bio Ord
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
September 19, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Nuclear Winter
February 11, 2022
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|